GOAL 2050 is a new global campaign.

The mission of GOAL 2050 is to
End the Transmission of Tuberculosis and HIV by 2050

Test | Trace | Treat | mRNA Vaccines | Vaccine Confidence


WHY GOAL 2050?

Because ending transmission of TB and HIV by 2050 is possible with the right tools and investment and can:

  • Save 2.5 Million Lives Every Year
  • Save $130 Billion Dollars Every Year
  • End the top-2 leading global causes of death by infectious disease
  • Create Vast Global Progress and Confidence



The right tools are possible to be delivered for the campaign to end transmission of TB and HIV by 2050:

  • Testing
  • Tracing
  • Treatments
  • mRNA Vaccines
  • Vaccine Confidence Campaign
  • Advance Purchase Agreements for Vaccines



Ending transmission of TB and HIV is possible by 2050 because:

  • mRNA vaccines are a transformative new technology for the critical missing tool. (The rest of the tools are available now)
  • 30 years is a long time; 75 million lives lost and $4 Trillion Dollars lost is absolutely unacceptable
  • “It always seems impossible until it’s done.” — Nelson Mandela

Cost of Tuberculosis (TB)

0 People Dead
$ 0

Cost of HIV/AIDS

0 People Dead
$ 0


The initial investment in mRNA Vaccines for GOAL 2050 will be generated from private investment in the Norvax AAA mRNA Vaccine Bond up to $800 million dollars.

The AAA bond finance will be used for development and manufacturing of transformative mRNA vaccines in the new UKvax Factory with modular localized mRNA vaccine factory scaling.

The new GOAL 2050 campaign is planned in cooperation with the mRNA Vaccine Consortium, The Vaccine Confidence Project and Global Public Health Stakeholders.

$800 million dollars is less than 3 DAYS COST of TB and HIV. ($350 million per day)

Norvax is leading the development of Vax Factory with the mRNA Universal Coronavirus Vaccine, the mRNA UCV Consortium, and Vaxcomm – Vaccine FTO Commons.

Learn More

The Modular Vax Factory with

mRNA Vaccine Platform by Norvax.

Learn More

Partnership with The Vaccine Confidence Project

VCP Mission. The purpose of the project is to monitor public confidence in immunisation programmes by building an information surveillance system for early detection of public concerns around vaccines; by applying a diagnostic tool to data collected to determine the risk level of public concerns in terms of their potential to disrupt vaccine programmes; and, finally, to provide analysis and guidance for early response and engagement with the public to ensure sustained confidence in vaccines and immunisation. This initiative also defines a Vaccine Confidence Index™ (VCI) as a tool for mapping confidence globally.

The Vaccine Confidence Project

Learn More

mRNA Vaccine Platform by Norvax
mRNA UCV Consortium with Norvax
Vaxcomm – The Vaccine FTO Commons
About mRNA Vaccine Technology
Advantages of mRNA Vaccines
Global Report on Tuberculosis Vaccines 2018
The Global Fund. Fighting Pandemics and Building a Healthier and More Equitable World
An Evaluation of Progress Towards the 2035 WHO End TB Targets in 40 High Burden Countries
UNAIDS. BREATH. Let’s end TB and AIDS by 2030
WHO. The End TB Strategy
WHO. Global Tuberculosis Programme
CDC. Diarrhea: Common Illness, Global Killer
Fact Sheet: The Biden-⁠Harris Administration Marks World AIDS Day 2021 With Renewed Commitments to Ending the HIV/AIDS Epidemic by 2030